Lexeo Therapeutics, Inc. Common Stock / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €440.15K
    Gross profit
    -€440.15K
    SG&A expenses
    €42.92M
    R&D expenses
    €63.59M
    EBITDA
    -€96.65M
    D&A
    €1.76M
    EBIT
    -€106.51M
    Interest expenses
    €131.18K
    EBT
    -€98.53M
    Tax expenses
    €0.00
    Net income
    -€98.53M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €6.06M
    Changes in working capital
    -€2.39M
    Operating cash flow
    -€82.05M
    Capex
    €142.40K
    Other investing cash flow
    -€80.78M
    Net investing cash flow
    -€101.18M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €68.83M
    Debt repayment
    -€438.42K
    Other financing cash flow
    -€5.92M
    Net financing cash flow
    €62.83M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€117.59M
    Cash at end of period
    €33.42M
    Free cash flow
    -€81.90M

    Balance sheet

    Cash and cash equivalents
    €30.62M
    Cash and short-term investments
    €114.69M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €6.19M
    Total current assets
    €120.88M
    Property, plant & equipment
    €8.42M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €19.85M
    Other non-current assets
    €2.80M
    Total non-current assets
    €31.07M
    Total assets
    €151.95M
    Accounts payable
    €17.28M
    Short-term debt
    €2.29M
    Other current liabilities
    €7.69M
    Total current liabilities
    €27.27M
    Long-term debt
    €5.40M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €5.40M
    Total liabilities
    €32.67M
    Common stock
    €4.32K
    Retained earnings
    -€292.51M
    Other equity
    -€11.22K
    Total equity
    €119.29M
    Total liabilities and shareholders' equity
    €151.95M

    Company information

    Market capitalization
    €116.66M
    Employees
    75
    Enterprise Value
    €130.20M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -82.6%
    ROA
    -64.8%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -70.5%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.31M

    Notifications